PUBLISHED: 16:44, Sat, Jan 2, 2021 | UPDATED: 17:10, Sat, Jan 2, 2021
Uğur Şahin, co-founder of German vaccine developer BioNTech, warned the situation across the bloc was far from “rosy”. He criticised Brussels for gambling on the approval of other COVID-19 vaccines instead of stocking up on those already on the market.
Earlier this month the UK became the first country to approve the Pfizer-BioNTech jab.
More than 600,000 Britons have since been inoculated.
Mr Şahin told German news magazine Der Spiegel: “It doesn't look so rosy right now.Insurance Loans Mortgage Attorney Credit Lawyer
“A gap has emerged because there's a lack of other vaccines that have received approval and we have to fill this gap with our vaccine.”
The EU has come under fire from the co-founder of BioNTech over the order of vaccines (Image: GETTY)
Uğur Şahin warned all is not 'rosy' in the EU on the vaccine front (Image: GETTY)
Commenting on the speed at which the EU is purchasing jabs, he added: "The process in Europe certainly wasn't as fast and straightforward as in other countries."
Reports suggest the EU has ordered around 300 million vaccine doses.
This is not nearly enough to immunise the bloc’s 446 million population.
The UK on the other hand has 30 million doses of the Pfizer-BioNTech jab and 100 million doses of the Oxford-AstraZeneca vaccine.
READ MORE: Tom Jones: The Voice UK star reveals he’s had the COVID-19 vaccine
Uğur Şahin, co-founder of German vaccine developer BioNTech (Image: GETTY)
The figures suggest there will be enough to vaccinate the entire population of the UK, given that each person